Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients
Ruijuan Cheng, Anji Xiong, Yanhong Li, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy
Mauro Krampera, Katarina Le Blanc
Cell stem cell (2021) Vol. 28, Iss. 10, pp. 1708-1725
Closed Access | Times Cited: 173
An updated advance of autoantibodies in autoimmune diseases
Ze Xiu Xiao, Joseph Miller, Song Guo Zheng
Autoimmunity Reviews (2020) Vol. 20, Iss. 2, pp. 102743-102743
Closed Access | Times Cited: 164
Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
Chenghai Li, Hua Zhao, Linna Cheng, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 110
The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review
Ana Bajc Česnik, Urban Švajger
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 19
Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus
Aifen Li, Fengbiao Guo, Quanren Pan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 81
Facile fabrication of a biocompatible composite gel with sustained release of aspirin for bone regeneration
Yunfan Zhang, Xueyu Dou, Lingyun Zhang, et al.
Bioactive Materials (2021) Vol. 11, pp. 130-139
Open Access | Times Cited: 79
Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases
Fangfang Huang, Erick Thokerunga, Fajian He, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 64
Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges
Noemí Eiró, María Fraile, Alberto González-Jubete, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8905-8905
Open Access | Times Cited: 40
Introduction to stem cells
Zeyu Tian, Tao Yu, Jun‐Ping Liu, et al.
Progress in molecular biology and translational science (2023), pp. 3-32
Closed Access | Times Cited: 30
Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives
Silvia Fernández-Francos, Noemí Eiró, Natalia González-Galiano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7850-7850
Open Access | Times Cited: 54
Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases
Yuling Huang, Lina Yang
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment — specific factors involved in the regulation of MSC plasticity
Liping Tan, Xuan Liu, Huan Dou, et al.
Genes & Diseases (2020) Vol. 9, Iss. 2, pp. 296-309
Open Access | Times Cited: 50
Current cell therapies for systemic lupus erythematosus
Lan T.M. Dao, Thu Thuy Vu, Quyen Thi Nguyen, et al.
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 9, pp. 859-872
Open Access | Times Cited: 6
An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis
Wenchao Li, Weiwei Chen, Lingyun Sun
Kidney Diseases (2021) Vol. 7, Iss. 2, pp. 79-89
Open Access | Times Cited: 39
Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
Akram Hoseinzadeh, Zahra Rezaieyazdi, Mahmoud Mahmoudi, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109699-109699
Closed Access | Times Cited: 13
MSCs-released TGFβ1 generate CD4+CD25+Foxp3+ in T-reg cells of human SLE PBMC
Dewi Masyithah Darlan, Delfitri Munir, Agung Putra, et al.
Journal of the Formosan Medical Association (2020) Vol. 120, Iss. 1, pp. 602-608
Open Access | Times Cited: 33
Glucocorticoid‐induced osteonecrosis in systemic lupus erythematosus patients
Kaichi Kaneko, Hao Chen, Matthew Kaufman, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 10
Open Access | Times Cited: 29
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
Shun Takao, Taku Nakashima, Takeshi Masuda, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Immunomodulatory performance of GMP-compliant, clinical-grade mesenchymal stromal cells from four different sources
Mandana Kazem Arki, Kasra Moeinabadi‐Bidgoli, Bahareh Niknam, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24948-e24948
Open Access | Times Cited: 4
INNOVATIVE THERAPEUTICS FOR RENOPROTECTION: WHERE WE ARE
Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi
Pharmacological Reviews (2025), pp. 100060-100060
Closed Access
The involving progress of MSCs based therapy in atherosclerosis
Ying Lin, Wei Zhu, Xiaohong Chen
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 31
Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis
Aidan M. Kirkham, Madeline Monaghan, Adrian Bailey, et al.
Cytotherapy (2022) Vol. 24, Iss. 6, pp. 639-649
Open Access | Times Cited: 18
The Therapeutic Use and Potential of MSCs: Advances in Regenerative Medicine
Alin Constantin Pînzariu, Roxana Moscalu, Radu Petru Soroceanu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3084-3084
Open Access
When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease
Sandra Calcat-i-Cervera, Clara Sanz‐Nogués, Timothy O’Brien
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 22
Safety and tolerability of bone marrow–derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans
Sehwan Chun, Chan‐Bum Choi, Min S. Kim, et al.
Lupus (2022) Vol. 31, Iss. 10, pp. 1245-1253
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top